These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16084945)

  • 1. Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substrates.
    d'Amati G; Bagattin A; Bauce B; Rampazzo A; Autore C; Basso C; King K; Romeo MD; Gallo P; Thiene G; Danieli GA; Nava A
    Hum Pathol; 2005 Jul; 36(7):761-7. PubMed ID: 16084945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Memmi M; Colombi B; Drago F; Gasparini M; DeSimone L; Coltorti F; Bloise R; Keegan R; Cruz Filho FE; Vignati G; Benatar A; DeLogu A
    Circulation; 2002 Jul; 106(1):69-74. PubMed ID: 12093772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.
    Nof E; Belhassen B; Arad M; Bhuiyan ZA; Antzelevitch C; Rosso R; Fogelman R; Luria D; El-Ani D; Mannens MM; Viskin S; Eldar M; Wilde AA; Glikson M
    Heart Rhythm; 2011 Oct; 8(10):1546-52. PubMed ID: 21699856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sudden unexpected cardiac death and postmortem identification of a novel RYR2 gene mutation.
    Mahlke N; Dittmann S; Schulze-Bahr E; Ritz-Timme S; Hartung B
    Int J Legal Med; 2019 Nov; 133(6):1835-1838. PubMed ID: 31289932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sudden death due to catecholaminergic polymorphic ventricular tachycardia following negative stress-test outcome: genetics and clinical implications.
    D'Ovidio C; Carnevale A; Grassi VM; Rosato E; Del Olmo B; Coll M; Campuzano O; Iglesias A; Brugada R; Oliva A
    Forensic Sci Med Pathol; 2017 Jun; 13(2):217-225. PubMed ID: 28405885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro.
    Marjamaa A; Laitinen-Forsblom P; Wronska A; Toivonen L; Kontula K; Swan H
    Int J Cardiol; 2011 Mar; 147(2):246-52. PubMed ID: 19781797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-ventricular, Clinical, and Functional Features of the RyR2(R420Q) Mutation Causing Catecholaminergic Polymorphic Ventricular Tachycardia.
    Domingo D; Neco P; Fernández-Pons E; Zissimopoulos S; Molina P; Olagüe J; Suárez-Mier MP; Lai FA; Gómez AM; Zorio E
    Rev Esp Cardiol (Engl Ed); 2015 May; 68(5):398-407. PubMed ID: 25440180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation.
    Nozaki Y; Kato Y; Uike K; Yamamura K; Kikuchi M; Yasuda M; Ohno S; Horie M; Murayama T; Kurebayashi N; Horigome H
    Circ J; 2020 Jan; 84(2):226-234. PubMed ID: 31875585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.
    Bauce B; Rampazzo A; Basso C; Bagattin A; Daliento L; Tiso N; Turrini P; Thiene G; Danieli GA; Nava A
    J Am Coll Cardiol; 2002 Jul; 40(2):341-9. PubMed ID: 12106942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A de novo ryanodine receptor 2 gene variant in a case of sudden cardiac death.
    Foti F; De-Giorgio F; Vetrugno G; Basso C; Pilichou K
    Int J Legal Med; 2020 Mar; 134(2):619-623. PubMed ID: 31605164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.
    Arakawa J; Hamabe A; Aiba T; Nagai T; Yoshida M; Touya T; Ishigami N; Hisadome H; Katsushika S; Tabata H; Miyamoto Y; Shimizu W
    Heart Vessels; 2015 Nov; 30(6):835-40. PubMed ID: 25092222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H
    Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest.
    Campbell MJ; Czosek RJ; Hinton RB; Miller EM
    Am J Med Genet A; 2015 Sep; 167A(9):2197-200. PubMed ID: 26018045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel RyR2 Mutation (G3118R) Is Associated With Autosomal Recessive Ventricular Fibrillation and Sudden Death: Clinical, Functional, and Computational Analysis.
    Shauer A; Shor O; Wei J; Elitzur Y; Kucherenko N; Wang R; Chen SRW; Einav Y; Luria D
    J Am Heart Assoc; 2021 Mar; 10(6):e017128. PubMed ID: 33686871
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kohli U; Kuntz L; Nayak HM
    Cardiol Young; 2020 Jul; 30(7):1039-1042. PubMed ID: 32513315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.
    Jiang D; Jones PP; Davis DR; Gow R; Green MS; Birnie DH; Chen SR; Gollob MH
    Channels (Austin); 2010; 4(4):302-10. PubMed ID: 20676041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
    Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new mutation in the ryanodine receptor 2 gene (RYR2 C2277R) as a cause catecholaminergic polymorphic ventricular tachycardia.
    Domingo D; López-Vilella R; Arnau MÁ; Cano Ó; Fernández-Pons E; Zorio E
    Rev Esp Cardiol (Engl Ed); 2015 Jan; 68(1):71-3. PubMed ID: 25435091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.